Company profile: Nutra Pharma
1.1 - Company Overview
Company description
- Provider of biopharmaceutical products, engaging in the acquisition, licensing, and commercialization of pharmaceutical products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nutra Pharma
Gilead
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for critical diseases, discovering, developing, manufacturing and commercializing treatments across virology, oncology and inflammation. Portfolio includes Biktarvy and Descovy for HIV-1 (treatment and PrEP) and Epclusa for HCV, with efforts to transform viral diseases into manageable conditions and expand access to care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gilead company profile →
Confo Therapeutics
HQ: Belgium
Website
- Description: Provider of GPCR-focused drug discovery solutions leveraging proprietary Confo® Technology and conformationally selective VHH ConfoBodies® to stabilize GPCRs in active, disease-relevant states. Offerings include ConfoScreen®, ConfoSensor®, and ConfoStructure™ for screening, biosensing, and structure-based design, and MegaBody™ for high-resolution cryo-EM, enabling novel medicine discovery and internal programs addressing unmet medical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Confo Therapeutics company profile →
Harbor Therapeutics
HQ: United States
Website
- Description: Provider of a proprietary class of adrenal steroid hormones developed as novel pharmaceuticals and potential nutraceuticals for human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harbor Therapeutics company profile →
NeRRe Therapeutics
HQ: United Kingdom
Website
- Description: Provider of biotechnology R&D focused on clinical and pre-clinical neurokinin receptor antagonists, including Orvepitant, a neurokinin-1 receptor antagonist in development for treating chronic cough associated with idiopathic pulmonary fibrosis (IPF). Founded in 2012 and based in Stevenage, United Kingdom.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeRRe Therapeutics company profile →
Corridor Pharmaceuticals
HQ: United States
Website
- Description: Provider of platform-based pulmonary and critical care therapeutics, developing and commercializing small-molecule inhibitors of arginase to address elevated arginase levels, targeting arginase—an enzyme that competes with endothelial nitric oxide synthase for l-arginine and leads to ornithine production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corridor Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nutra Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nutra Pharma
2.2 - Growth funds investing in similar companies to Nutra Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nutra Pharma
4.2 - Public trading comparable groups for Nutra Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →